Kelly Finan, MD
Colon & Rectal Surgery · Baton Rouge, LANPI 1295940559
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Applied Medical Resources Corporation accounts for 94.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $11,654 and has fallen 97.7% since, to $268 in 2025.
Across 49 payments — averaging $258.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$12K
- Medtronic$240
- Kerecis Limited$131
- Dilon Technologies, Inc.$116
- Innovation Technologies Inc$46
- Merck$37
- plus $194 from 9 others
What the payments were for
- Consulting fees$6,75053%
- Speaking & faculty fees$3,00024%
- Travel & lodging$1,91015%
- Food & beverage$1,0028%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 15 | $11,898 |
| Medtronic | 11 | $240 |
| Kerecis Limited | 7 | $131 |
| Dilon Technologies, Inc. | 3 | $116 |
| Innovation Technologies Inc | 2 | $46 |
| Merck | 2 | $37 |
| Baxter Healthcare | 1 | $35 |
| Sanara Medtech Inc. | 1 | $28 |
| Heron Therapeutics, Inc. | 1 | $24 |
| Cook Medical LLC | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Axonics, Inc. | 1 | $15 |
| TELA Bio, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,662 in reported general payments places this provider in the 70th percentile of 39 colon & rectal surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 62 | $4,336 |
| Neomycin Sulfate | 27 | $161 |
| Metronidazole | 30 | $57 |
| Ibuprofen | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Baton Rouge
- Louis BarfieldBaton Rouge$17K
- Ray DaughertyBaton Rouge$10K
- Nathan HiteBaton Rouge$9K
- Jaclyn IsabellaBaton Rouge$6K
- Matthew GigliaBaton Rouge$5K
- Richard ByrdBaton Rouge$3K
- Brian CarrBaton Rouge$850
- Jay JhunjhunwalaBaton Rouge$78
- Jennifer ParuchNew Orleans$63K
- Andrew WernerShreveport$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.